Dr. Reddy's Laboratories’ American subsidiary is recalling 571 vials of an injection used to relax muscles. Princeton-based Dr Reddy's is recalling the affected lot of Succinylcholine Chloride injection due to out-of-specification result during the six-month stability testing. The company initiated the nationwide (US) Class II recall on September 26 this year.
As per the USFDA, a Class-II recall is initiated when the use of, or exposure to, a violative product may lead to temporary or medically reversible health consequences, or when the likelihood of serious adverse health outcomes is minimal.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
